Strumento inattivo

Azioni Mapi Pharma Ltd

Azioni

Prezzo di chiusura Nasdaq Altri mercati azionari
- ^USD	-

Mapi Pharma : Closes $10 Million Investment Led by Shavit Capital	27/05/15
Mapi Pharma : First Patient Treated in Mapi Pharma’s Phase IIa Clinical Trial of GA Depot for Relapsing Remitting Multiple Sclerosis (RRMS)	17/12/14

Dirigenti	Titolo	Età	Da
Ehud Marom CEO	Chief Executive Officer	73	01/01/08
Nir Bernstein DFI	Director of Finance/CFO	57	01/11/13
Laura Popper CTO	Chief Tech/Sci/R&D Officer	-	-

Amministratori	Titolo	Età	Da
Dov Pekelman BRD	Director/Board Member	84	-
Ehud Marom CEO	Chief Executive Officer	73	01/01/08
Itamar Borowitz BRD	Director/Board Member	80	01/05/09

Settore

	Variaz. 1 gen.	Capi.
VERTEX PHARMACEUTICALS INCORPORATED	+9,42%	115 Mrd
REGENERON PHARMACEUTICALS, INC.	+11,84%	106 Mrd
ARGENX SE	-1,05%	21,96 Mrd
BIONTECH SE	-14,15%	21,87 Mrd
GENMAB A/S	-5,29%	19,21 Mrd
BEIGENE, LTD.	-4,16%	18,08 Mrd
WUXI APPTEC CO., LTD.	-38,29%	17,71 Mrd
NEUROCRINE BIOSCIENCES, INC.	+7,99%	14,32 Mrd
SAREPTA THERAPEUTICS, INC.	+36,24%	12,42 Mrd